BRIEF-Evelo Biosciences Says Co And Abdul Latif Jameel Health Entered Strategic Collaboration

PUBLISHED: Tue, 23 Mar 2021 11:53:43 GMT
Share

March 23 (Reuters) – Evelo Biosciences Inc:

* CO AND ABDUL LATIF JAMEEL HEALTH ENTERED INTO A STRATEGIC COLLABORATION

* EVELO BIOSCIENCES-STRATEGIC COLLABORATION TO DEVELOP AND COMMERCIALIZE CO’S LEAD INFLAMMATION PRODUCT CANDIDATE EDP1815 IN MIDDLE EAST, TURKEY, AFRICA Source text for Eikon: Further company coverage:

(c) Copyright Thomson Reuters 2021. Click For Restrictions – https://agency.reuters.com/en/copyright.html

Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.